Skip to search formSkip to main contentSkip to account menu

Vulvovaginal atrophy

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
ABSTRACT Introduction: Despite its frequency, recognition and therapy of vulvovaginal atrophy (VVA) remain suboptimal. Wet mount… 
Review
2017
Review
2017
Objectives: Intravaginal testosterone has emerged as a potential treatment for vulvovaginal atrophy (VVA) in women, in general… 
Highly Cited
2017
Highly Cited
2017
Objective: The aim of the study was to evaluate efficacy of fractional CO2 vaginal laser treatment (Laser, L) and compare it to… 
Highly Cited
2016
Highly Cited
2016
Objectives:Breast cancer is one of the most common malignancies in women. Hormonal treatment and chemotherapy induce a transient… 
Review
2015
Review
2015
Abstract Vaginal dryness is a common condition that is particularly prevalent during and after the menopause, and is one of the… 
Highly Cited
2014
Highly Cited
2014
ObjectiveThe vaginal microbiota helps protect the female genital tract from disease. We sought to describe the composition of the… 
Highly Cited
2014
Highly Cited
2014
Objective This pilot study aimed to assess the efficacy in treating sexually active menopausal patients who had dyspareunia… 
Review
2013
Review
2013
Introduction Vaginal atrophy, which may affect up to 45% of postmenopausal women, is often associated with one or more urinary… 
Review
2013
Review
2013
ABSTRACT Vulvovaginal atrophy-related symptoms exert a negative impact on the quality of life of up to 50% of postmenopausal…